Search Within

Gregory J Riely

  1. "Darragh Halpenny"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (5)
Groups
  1. Department of Medicine (16)
  2. Solid Tumor Oncology Division (16)
  3. Thoracic Oncology (16)
  4. Body Imaging Service (13)
  5. Epidemiology and Biostatistics (13)
  6. Radiology, Department of (13)

More Groups

People
  1. Darragh Halpenny (16)
  2. Matthew Hellmann (12)
  3. Andrew Plodkowski (11)
  4. Charles Rudin (8)
  5. Kathryn Arbour (8)
  6. Ai Ni (7)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (4)
  4. 2018 (6)
  5. 2017 (3)
  6. 2014 (1)
Publications
  1. Journal of Clinical Oncology (6)
  2. Lung Cancer (3)
  3. Annals of Oncology (2)
  4. Journal of Thoracic Oncology (2)
  5. British Journal of Cancer (1)
  6. Clinical Imaging (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. Elsevier Inc. (3)
  3. Elsevier Ireland Ltd. (3)
  4. Oxford University Press (2)
  5. Nature Publishing Group (1)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Clinical characteristics and anti-PD-(L)1 treatment outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
    Meeting Abstract

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Halpenny, D.; Hellmann, M. D.; Heller, G.; Knezevic, A.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Lesion-level response dynamics to programmed cell death protein (PD-1) blockade
    Journal Article

    Osorio, J. C.; Arbour, K. C.; Le, D. T.; Durham, J. N.; Plodkowski, A. J.; Halpenny, D. F.; Ginsberg, M. S.; Sawan, P.; Crompton, J. G.; Yu, H. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Molecular characteristics, immunophenotype, and immune checkpoint inhibitor response in BRAF non-V600 mutant lung cancers
    Meeting Abstract

    Offin, M.; Pak, T.; Mondaca, S.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Wu, S.; Kris, M.; Paik, P.; Riely, G.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
    Journal Article

    Hastings, K.; Yu, H. A.; Wei, W.; Sanchez-Vega, F.; DeVeaux, M.; Choi, J.; Rizvi, H.; Lisberg, A.; Truini, A.; Lydon, C. A.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Immunophenotype and response to immunotherapy of RET-rearranged lung cancers
    Journal Article

    Offin, M.; Guo, R.; Wu, S. L.; Sabari, J.; Land, J. D.; Ni, A.; Montecalvo, J.; Halpenny, D. F.; Buie, L. W.; Pak, T.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • RET-rearranged lung cancers: Immunophenotype and response to immunotherapy
    Meeting Abstract

    Sabari, J. K.; Offin, M. D.; Wu, S. L.; Ni, A.; Halpenny, D.; Montecalvo, J.; Liu, D.; Pak, T. K.; Arbour, K. C.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Deleterious effect of baseline steroids on efficacy of PD-(L)1 blockade in patients with NSCLC
    Meeting Abstract

    Arbour, K. C.; Mezquita, L.; Long, N.; Rizvi, H.; Auclin, E.; Ni, A.; Bernal, G. M.; Chaft, J. E.; Ferrara, R.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent mutations in STK11 and KEAP1 is associated with resistance to PD-(L)1 blockade in patients with NSCLC despite high TMB
    Meeting Abstract

    Arbour, K.; Shen, R.; Plodkowski, A.; Rizvi, H.; Ni, A.; Long, N.; Halpenny, D.; Sanchez-Vega, F.; Rudin, C.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers
    Journal Article

    Sabari, J. K.; Leonardi, G. C.; Shu, C. A.; Umeton, R.; Montecalvo, J.; Ni, A.; Chen, R.; Dienstag, J.; Mrad, C.; Bergagnini, I.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save